American Century Companies Inc. Has $82.33 Million Position in Sanofi (NASDAQ:SNY)

American Century Companies Inc. raised its stake in shares of Sanofi (NASDAQ:SNY) by 1.8% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,707,057 shares of the company’s stock after purchasing an additional 29,536 shares during the period. American Century Companies Inc.’s holdings in Sanofi were worth $82,331,000 as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. Charles Schwab Investment Management Inc. boosted its stake in Sanofi by 31.1% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 139,505 shares of the company’s stock valued at $8,040,000 after purchasing an additional 33,105 shares during the period. Arkadios Wealth Advisors lifted its holdings in shares of Sanofi by 19.0% during the fourth quarter. Arkadios Wealth Advisors now owns 4,709 shares of the company’s stock worth $227,000 after buying an additional 751 shares during the last quarter. Geode Capital Management LLC boosted its position in shares of Sanofi by 7.1% in the third quarter. Geode Capital Management LLC now owns 254,738 shares of the company’s stock valued at $14,681,000 after acquiring an additional 16,780 shares during the period. JPMorgan Chase & Co. grew its stake in shares of Sanofi by 20.9% in the third quarter. JPMorgan Chase & Co. now owns 2,310,809 shares of the company’s stock worth $133,172,000 after acquiring an additional 399,301 shares during the last quarter. Finally, Kentucky Trust Co bought a new position in Sanofi during the fourth quarter worth $436,000. Institutional investors own 14.04% of the company’s stock.

Sanofi Stock Down 1.7 %

Shares of SNY opened at $55.93 on Tuesday. The company has a quick ratio of 1.14, a current ratio of 1.46 and a debt-to-equity ratio of 0.15. The company has a 50-day moving average price of $54.70 and a two-hundred day moving average price of $52.84. The stock has a market cap of $141.94 billion, a price-to-earnings ratio of 22.46, a P/E/G ratio of 1.01 and a beta of 0.58. Sanofi has a 12 month low of $45.22 and a 12 month high of $60.12.

Sanofi (NASDAQ:SNY) last issued its earnings results on Thursday, January 30th. The company reported $0.70 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.70. Sanofi had a return on equity of 25.61% and a net margin of 12.77%. Equities analysts predict that Sanofi will post 4.36 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

SNY has been the topic of several research analyst reports. Sanford C. Bernstein upgraded shares of Sanofi to a “strong-buy” rating in a research report on Thursday, January 30th. StockNews.com downgraded Sanofi from a “buy” rating to a “hold” rating in a research report on Thursday, December 12th. The Goldman Sachs Group began coverage on Sanofi in a report on Friday. They issued a “neutral” rating and a $65.00 price target for the company. Finally, Deutsche Bank Aktiengesellschaft upgraded Sanofi from a “sell” rating to a “hold” rating in a research report on Thursday, January 30th. Three investment analysts have rated the stock with a hold rating, one has given a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $62.50.

About Sanofi

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.